Previously treated cases tested for RR-/MDR-TB in Papua New Guinea

Papua New Guinea: Previously treated cases tested for RR-/MDR-TB was 100.0% in 2024. ▲ Rising

Latest (2024)
100.0%
Change on year
unchanged
World rank
1st
of 180 countries
All-time high
100.0%
in 2023
All-time low
13.0%
in 2016
Years of data
5
2015–2024

Previously treated cases tested for RR-/MDR-TB in Papua New Guinea, 2015–2024

204060801002015201920242015: 612016: 132017: 562023: 1002024: 100

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for previously treated cases tested for rr-/mdr-tb in Papua New Guinea is 100.0%, measured in 2024. That is the highest value across all 5 years on record.

Compared with earlier readings it is up 63.9% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Papua New Guinea peaked at 100.0% in 2023 and was at its lowest, 13.0%, in 2016.

Papua New Guinea ranks 1st of 180 countries on this measure, in the top 10%.

Previously treated cases tested for RR-/MDR-TB in Papua New Guinea, year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Papua New Guinea, 2015 to 2024.
Year Value Change
2015 61.0%
2016 13.0% -78.7%
2017 56.0% +330.8%
2023 100.0% +78.6%
2024 100.0% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 43.3% 13.0% 61.0% 3
2020s 100.0% 100.0% 100.0% 2

Countries ranked near Papua New Guinea

  1. 1 Côte d'Ivoire 100.0% compare
  2. 1 Zambia 100.0% compare
  3. 1 Lithuania 100.0% compare
  4. 1 Slovenia 100.0% compare
  5. 1 Sri Lanka 100.0% compare
  6. 1 Bangladesh 100.0% compare
  7. 1 Fiji 100.0% compare
  8. 1 Norway 100.0% compare
  9. 1 Kuwait 100.0%
  10. 1 Luxembourg 100.0% compare
  11. 1 Armenia 100.0% compare
  12. 1 Gambia 100.0% compare
  13. 1 Ghana 100.0% compare
  14. 1 Yemen 100.0% compare
  15. 1 Oman 100.0% compare
  16. 1 Brunei Darussalam 100.0% compare
  17. 1 Togo 100.0% compare
  18. 1 Israel 100.0% compare
  19. 1 Cameroon 100.0% compare
  20. 1 Jamaica 100.0% compare
  21. 1 Eritrea 100.0% compare
  22. 1 Cyprus 100.0% compare
  23. 1 Montenegro 100.0% compare
  24. 1 Sao Tome and Principe 100.0% compare
  25. 1 Viet Nam 100.0% compare
  26. 1 Belize 100.0% compare
  27. 1 Marshall Islands 100.0% compare
  28. 1 Republic of Moldova 100.0% compare
  29. 1 Comoros 100.0% compare
  30. 1 Kazakhstan 100.0% compare
  31. 1 Lao People's Democratic Republic 100.0% compare
  32. 1 Antigua and Barbuda 100.0% compare
  33. 1 Afghanistan 100.0% compare
  34. 1 Benin 100.0% compare
  35. 1 Jordan 100.0% compare
  36. 1 Puerto Rico 100.0% compare
  37. 1 Saint Vincent and the Grenadines 100.0% compare
  38. 1 Mauritius 100.0% compare
  39. 1 Congo 100.0% compare
  40. 1 Eswatini 100.0% compare
  41. 1 Micronesia, Federated States of 100.0% compare
  42. 1 Iceland 100.0% compare
  43. 1 Belarus 100.0% compare
  44. 1 Albania 100.0% compare
  45. 1 Mauritania 100.0% compare
  46. 1 Bhutan 100.0% compare
  47. 1 Tuvalu 100.0% compare
  48. 1 Malta 100.0% compare
  49. 1 Iraq 100.0% compare
  50. 1 Republic of Korea 100.0% compare
  51. 1 Bahamas 100.0% compare
  52. 1 Zimbabwe 100.0% compare
  53. 1 Andorra 100.0%
  54. 1 Turkmenistan 100.0% compare

See the full ranking of 193 places →

More health data for Papua New Guinea

All data for Papua New Guinea →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Papua New Guinea?
Previously treated cases tested for rr-/mdr-tb in Papua New Guinea was 100.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Papua New Guinea?
The highest recorded value was 100.0% in 2023.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Papua New Guinea?
The lowest recorded value was 13.0% in 2016.
How does Papua New Guinea rank for previously treated cases tested for rr-/mdr-tb?
Papua New Guinea ranks 1st out of 180 countries with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in Papua New Guinea?
Over the last ten years it is up 63.9%. The long-run trend across the full record is rising.
Where does this Papua New Guinea data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Papua New Guinea. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 02 September 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/papua-new-guinea/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/papua-new-guinea/">Previously treated cases tested for RR-/MDR-TB in Papua New Guinea</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed